Stuart Kells does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

The Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs. The collaboration ...